Four years survival in autologous stem cell transplantation with moderate dose of idarubicin and busulphan as conditioning regimen in acute myelogenous leukemia A.V. was a 32 yo woman who was found to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results